Cargando…
Chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085934/ https://www.ncbi.nlm.nih.gov/pubmed/35558262 http://dx.doi.org/10.21037/tau-22-20 |
_version_ | 1784703928338743296 |
---|---|
author | Li, Hung-Keng Chung, Shiu-Dong |
author_facet | Li, Hung-Keng Chung, Shiu-Dong |
author_sort | Li, Hung-Keng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9085934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-90859342022-05-11 Chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients Li, Hung-Keng Chung, Shiu-Dong Transl Androl Urol Letter to the Editor AME Publishing Company 2022-04 /pmc/articles/PMC9085934/ /pubmed/35558262 http://dx.doi.org/10.21037/tau-22-20 Text en 2022 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Letter to the Editor Li, Hung-Keng Chung, Shiu-Dong Chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients |
title | Chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients |
title_full | Chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients |
title_fullStr | Chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients |
title_full_unstemmed | Chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients |
title_short | Chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients |
title_sort | chronic kidney disease stages, intravesical therapy regimens, and regular cystoscopic follow-up may also impact the survival of urinary tract urothelial carcinoma patients |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085934/ https://www.ncbi.nlm.nih.gov/pubmed/35558262 http://dx.doi.org/10.21037/tau-22-20 |
work_keys_str_mv | AT lihungkeng chronickidneydiseasestagesintravesicaltherapyregimensandregularcystoscopicfollowupmayalsoimpactthesurvivalofurinarytracturothelialcarcinomapatients AT chungshiudong chronickidneydiseasestagesintravesicaltherapyregimensandregularcystoscopicfollowupmayalsoimpactthesurvivalofurinarytracturothelialcarcinomapatients |